Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

A 20-year-old woman was diagnosed with stage 4 lung adenocarcinoma with an epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation. Although the patient underwent chemotherapy, her lesions progressed. Liquid biopsy for EGFR T790M mutation showed negative results. After administering...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EXCLI J
Huvudupphovsmän: Murano, Chihiro, Igarashi, Akira, Yamauchi, Keiko, Inoue, Sumito, Watanabe, Masafumi
Materialtyp: Artigo
Språk:Inglês
Publicerad: Leibniz Research Centre for Working Environment and Human Factors 2019
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6806250/
https://ncbi.nlm.nih.gov/pubmed/31645848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1786
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk